What is the equivalent oral (PO) dose of metoprolol (tartrate) for a patient receiving 5 mg of metoprolol (metoprolol tartrate) intravenously (IV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Conversion of Metoprolol IV Tartrate 5 mg to PO Dosing

The equivalent oral dose of metoprolol tartrate for a patient receiving 5 mg IV is 50 mg PO, based on a 1:10 conversion ratio from IV to oral dosing. 1

Evidence-Based Conversion Ratios

The conversion from intravenous to oral metoprolol follows a well-established ratio:

  • A 10:1 ratio is used when converting from IV to oral metoprolol dosing
  • 5 mg IV metoprolol tartrate is approximately equivalent to 50 mg oral metoprolol tartrate 1

Pharmacokinetic Considerations

When converting from IV to oral metoprolol, several factors should be considered:

  • Metoprolol tartrate is an immediate-release formulation requiring twice-daily (BID) dosing
  • The oral bioavailability of metoprolol tartrate is approximately 50% due to first-pass metabolism
  • This reduced bioavailability necessitates the 10:1 conversion ratio from IV to oral dosing
  • Peak plasma concentrations occur 1-2 hours after oral administration 1, 2

Dosing Recommendations

When transitioning from IV to oral metoprolol tartrate:

  • For a patient receiving 5 mg IV metoprolol tartrate, prescribe 50 mg PO metoprolol tartrate
  • Standard oral dosing of metoprolol tartrate is typically 25-100 mg BID 1
  • If once-daily dosing is preferred for adherence reasons, consider converting to metoprolol succinate (extended-release) at an equivalent daily dose 1, 3

Clinical Pearls and Caveats

  • Monitor heart rate, blood pressure, and symptoms when transitioning from IV to oral therapy
  • If the patient has renal or hepatic impairment, consider starting with a lower oral dose
  • For patients with heart failure, initiate at a lower dose (12.5-25 mg BID of tartrate) and gradually titrate up 1, 4
  • If the patient has difficulty with twice-daily dosing, metoprolol succinate (extended-release) can be given once daily at the same total daily dose 1, 3

Alternative Formulation Considerations

If considering a switch to metoprolol succinate (extended-release):

  • 50 mg of metoprolol tartrate twice daily (100 mg total daily dose) is equivalent to 100 mg of metoprolol succinate once daily
  • Metoprolol succinate provides more consistent plasma concentrations over 24 hours 1, 2, 3
  • Once-daily dosing with metoprolol succinate may improve medication adherence compared to twice-daily regimens with metoprolol tartrate 1

Remember that the goal of beta-blocker therapy is to improve symptoms and quality of life while preventing adverse cardiovascular outcomes, with target heart rates typically 60-80 bpm at rest and less than 110 bpm with moderate activity.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.